Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Berlin Cures Holding Logo
Berlin Cures Holding Growth Score
82
CB Rank
2437266
Heat Score
57
Berlin Cures Holding AG develops aptamer-based therapeutics targeting functional autoantibodies.
Founded
obfuscation
Private Zug, Zug, Switzerland11-50 www.berlincures.ch
Manufacturing
Pharmaceutical
Therapeutics
Overview

Berlin Cures Holding
Growth Score
82
Heat Score
57

Growth Score82
-3 pts
in past quarter
Heat Score 57
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Berlin Cures Holding

CB Rank
2437266
Berlin Cures Holding AG develops aptamer-based therapeutics targeting functional autoantibodies.
Founded
obfuscation
Private Zug, Zug, Switzerland11-50 www.berlincures.ch
Manufacturing
Pharmaceutical
Therapeutics

Key People

Details

Legal Name Berlin Cures Holding AG
Operating Status Active
Company Type For Profit
Founders  Marko Bagaric
Contact Email info@berlincures.de
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

BC 007
A DNA-based aptamer designed to neutralize functional autoantibodies against G protein-coupled receptors, used in treating diseases like heart failure and Long COVID.
Functional Autoantibody Detection
A bioassay developed to test for the presence of functional autoantibodies in blood samples, used to monitor the effect of BC 007 treatment.

Research & Development

Berlin Cures Holding is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News

News and Press

News•Nov 28, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

2Berlin Cures Holding is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.

Total IP

1Berlin Cures Holding has 1 registered patent in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Berlin Cures Holding's headquarters? Berlin Cures Holding is located in Zug, Zug, Switzerland.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(b944491 1)
|